Variables | Control group (n = 107) | Study group (n = 47) | p-value |
---|---|---|---|
Age (years) | 81.5 ± 7.0 | 81.5 ± 6.3 | 0.971 |
Gender (male: female) | 32: 75 | 11: 36 | 0.408 |
Time to operation (days) | 2.7 ± 3.6 | 2.3 ± 1.5 | 0.546 |
ASA grade | 0.405 | ||
II | 4 | 0 | |
III | 94 | 43 | |
IV | 9 | 4 | |
BMI (kg/m2) | 21.7 ± 4.0 | 22.2 ± 4.1 | 0.524 |
BMD (T-score) | −3.04 ± 1.15 | −2.91 ± 1.03 | 0.535 |
Preoperative Hb (g/dL) | 11.2 ± 1.5 | 10.8 ± 1.3 | 0.201 |
Preoperative Hct (%) | 33.3 ± 4.5 | 32.6 ± 3.5 | 0.323 |
Underlying disease | |||
Cardiovascular | 83(77.6%) | 45(95.7%) | 0.006 |
Endocrinologic | 29(27.1%) | 24(51.1%) | 0.004 |
Pulmonary | 10(9.3%) | 3(6.4%) | 0.755 |
Neurologic | 27(25.2%) | 12(25.5%) | 0.969 |
Nephrologic | 11(10.3%) | 6(12.8%) | 0.650 |
Hemato-oncologic | 15(14.0%) | 6(12.8%) | 0.835 |